Silverarc Capital Management »

Gilead Sciences shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Gilead Sciences (GILD) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Gilead Sciences

Tip: Access up to 7 years of quarterly data

All positions including Gilead Sciences held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gilead Sciences by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.7M 63k 74.94
2023-06-30 $4.7M 60k 77.07
2023-03-31 $5.0M 60k 82.97
2022-12-31 $4.5M 52k 85.85

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Gilead Sciences

BlackRock
Vanguard Group
Dodge & Cox
Geode Capital Management
Wellington Management Company
Morgan Stanley
FMR
Bank of New York Mellon
Northern Trust
Legal & General Group
Dimensional Fund Advisors
Ubs Global Asset Management Americas
Amundi
Nuveen Asset Management
Citadel Advisors

View all funds holding Gilead Sciences